Catalent Inc. (NYSE: CTLT) stock closed at 100.97 per share at the end of the most recent trading day (a 4.43% change compared to the prior day closing price) with a volume of 669.33K shares and market capitalization of 18.10B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 17300 people. Catalent Inc. CEO is John R. Chiminski.

The one-year performance of Catalent Inc. stock is -7.2%, while year-to-date (YTD) performance is -21.14%. CTLT stock has a five-year performance of 180.55%. Its 52-week range is between 86.34 and 142.64, which gives CTLT stock a 52-week price range ratio of 25.99%

Catalent Inc. currently has a PE ratio of 36.00, a price-to-book (PB) ratio of 3.88, a price-to-sale (PS) ratio of 3.75, a price to cashflow ratio of 35.00, a PEG ratio of 2.32, a ROA of 5.21%, a ROC of 7.45% and a ROE of 11.92%. The company’s profit margin is 10.85%, its EBITDA margin is 23.20%, and its revenue ttm is $4.70 Billion , which makes it $26.24 revenue per share.

Of the last four earnings reports from Catalent Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.89 for the next earnings report. Catalent Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Catalent Inc. is Strong Buy (1.32), with a target price of $140.6, which is +39.25% compared to the current price. The earnings rating for Catalent Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Catalent Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Catalent Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.83, ATR14 : 4.02, CCI20 : 61.91, Chaikin Money Flow : 0.08, MACD : 0.13, Money Flow Index : 45.86, ROC : 6.88, RSI : 55.13, STOCH (14,3) : 92.26, STOCH RSI : 1.00, UO : 51.54, Williams %R : -7.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Catalent Inc. in the last 12-months were: Alessandro Maselli (Sold 4 736 shares of value $603 083 ), Aristippos Gennadios (Sold 2 727 shares of value $349 187 ), Gregory T. Lucier (Sold 5 068 shares of value $645 407 ), John R. Chiminski (Sold 0 shares of value $-2 986 972 ), John R. Chiminski (Sold 208 262 shares of value $27 069 357 ), Jonathan Arnold (Sold 0 shares of value $-338 421 ), Jonathan Arnold (Sold 12 905 shares of value $1 782 080 ), Karen A. Flynn (Sold 2 472 shares of value $288 334 ), Kay A Schmidt (Sold 3 563 shares of value $457 590 ), Michael J. Grippo (Sold 4 204 shares of value $544 204 ), Peter Zippelius (Sold 3 487 092 shares of value $437 899 992 ), Ricardo Pravda (Sold 0 shares of value $-241 694 ), Ricardo Pravda (Sold 8 856 shares of value $1 103 071 ), Ricci S Whitlow (Sold 184 shares of value $18 836 ), Ricky Hopson (Sold 4 156 shares of value $473 974 ), Scott Gunther (Sold 5 252 shares of value $667 692 ), Steven L. Fasman (Sold 0 shares of value $-889 050 ), Steven L. Fasman (Sold 46 874 shares of value $5 950 785 ), Thomas P. Castellano (Sold 4 955 shares of value $646 339 )